|
Dr. Mark C. Allen received his BSc degree in Chemistry from Exeter University and his MPhil and PhD degrees from the Council for National Academic Awards after periods of postgraduate study at the Universities of Plymouth and Brighton. Dr. Allen is a Chartered Chemist and a Fellow of the Royal Society of Chemistry. He joined CIBA-Geigy Pharmaceuticals UK Ltd. in 1975. In 1994 after progressing through the organization in both the UK and the US, Dr. Allen was appointed Head of Core Drug Discovery Technologies for CIBA Pharmaceuticals UK where he was responsible for all analytical chemistry, combinatorial chemistry, scale-up chemistry and molecular modeling activities. Following the formation of Novartis in early 1997, Dr Allen was appointed Head of Drug Discovery Support for Novartis Pharmaceuticals UK. He joined Tripos Discovery Research Ltd in 1998 as Director of Research & Analytics and Deputy Managing Director. He was promoted to Vice President, Head of Operations in 1999, where his responsibilities included the direction and management of all scientific activities at Tripos Discovery Research. In 2005, he was promoted to Senior Vice President, Discovery Research. | 